SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '7LV'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 9	GLY A 18 VAL A 25 ALA A 38 TYR A 88 LEU A 139	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.9A)	0.49A	1muoA-5tvtA: 11.3	1muoA-5tvtA: 28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T46_A_STIA3_1 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 57 LEU A 61 GLY A 92 LEU A 139 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) None None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	1.01A	1t46A-5tvtA: 22.2	1t46A-5tvtA: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	ALA A 38 GLU A 57 LEU A 61 CYH A 89 HIS A 130	7LV A 401 (-3.4A) 7LV A 401 (-3.5A) None 7LV A 401 (-4.3A) None	0.69A	1uwhA-5tvtA: 23.7	1uwhA-5tvtA: 26.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 12	ALA A 38 LYS A 40 GLU A 57 LEU A 61 CYH A 89 HIS A 130	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) None 7LV A 401 (-4.3A) None	0.71A	1uwhB-5tvtA: 23.6	1uwhB-5tvtA: 26.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 7	ILE A 17 LEU A 61 ILE A 69 ASP A 150	7LV A 401 (-4.3A) None None 7LV A 401 (-4.2A)	0.89A	1uwjA-5tvtA: 7.3	1uwjA-5tvtA: 26.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 7	ILE A 17 LYS A 40 LEU A 61 ILE A 69	7LV A 401 (-4.3A) 7LV A 401 (-3.0A) None None	0.75A	1uwjA-5tvtA: 7.3	1uwjA-5tvtA: 26.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 11	GLY A 18 GLY A 20 VAL A 25 ALA A 38 TYR A 88 LEU A 139	7LV A 401 ( 3.9A) 7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.9A)	0.64A	2evaA-5tvtA: 23.5	2evaA-5tvtA: 28.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 12	GLY A 18 VAL A 25 ALA A 38 LEU A 86 TYR A 88 ASP A 150	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 ( 4.2A) 7LV A 401 (-4.6A) 7LV A 401 (-4.2A)	0.52A	2wgjA-5tvtA: 22.6	2wgjA-5tvtA: 23.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ILE A 17 ALA A 38 LYS A 40 GLU A 57 TYR A 88 GLY A 92 LEU A 139	7LV A 401 (-4.3A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) None 7LV A 401 (-4.9A)	0.85A	2y6oA-5tvtA: 23.1	2y6oA-5tvtA: 26.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0E_A_B49A9000_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 11	VAL A 25 ALA A 38 TYR A 88 CYH A 89 GLY A 92 LEU A 139	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A)	0.40A	3g0eA-5tvtA: 21.4	3g0eA-5tvtA: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 11	VAL A 25 ALA A 38 TYR A 88 CYH A 89 GLY A 92 LEU A 139	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A)	0.39A	3g0fA-5tvtA: 22.4	3g0fA-5tvtA: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 10	VAL A 25 ALA A 38 TYR A 88 CYH A 89 GLY A 92 LEU A 139	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A)	0.43A	3g0fB-5tvtA: 22.4	3g0fB-5tvtA: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	VAL A 25 ALA A 38 LYS A 40 CYH A 89 PHE A 151	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-4.3A) None	0.79A	3og7A-5tvtA: 23.3	3og7A-5tvtA: 26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_B_1N1B1000_1 (P38A)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	GLY A 18 VAL A 25 ALA A 38 LYS A 40 LEU A 61	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) None	0.52A	3ohtB-5tvtA: 6.4	3ohtB-5tvtA: 23.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	VAL A 25 ALA A 38 GLU A 57 MET A 84 TYR A 88 LEU A 139 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.5A) None 7LV A 401 (-4.6A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	1.22A	4bkjA-5tvtA: 22.0	4bkjA-5tvtA: 23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	9 / 12	VAL A 25 ALA A 38 ASP A 96 ASP A 132 LYS A 134 ASN A 137 LEU A 139 ILE A 149 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) None None None None 7LV A 401 (-4.9A) 7LV A 401 (-3.6A) 7LV A 401 (-4.2A)	0.77A	4i41A-5tvtA: 27.7	4i41A-5tvtA: 29.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 11	ALA A 38 LEU A 86 GLU A 136 LEU A 139 ILE A 149 ASP A 150	7LV A 401 (-3.4A) 7LV A 401 ( 4.2A) None 7LV A 401 (-4.9A) 7LV A 401 (-3.6A) 7LV A 401 (-4.2A)	1.16A	4iaaA-5tvtA: 27.7	4iaaA-5tvtA: 30.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 11	VAL A 25 ALA A 38 LYS A 40 LEU A 86 LEU A 139 ILE A 149 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 ( 4.2A) 7LV A 401 (-4.9A) 7LV A 401 (-3.6A) 7LV A 401 (-4.2A)	0.64A	4iaaA-5tvtA: 27.7	4iaaA-5tvtA: 30.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 12	GLY A 18 VAL A 25 ALA A 38 LEU A 72 GLY A 92 GLU A 93 LEU A 139 ILE A 149	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) None None 7LV A 401 ( 4.7A) 7LV A 401 (-4.9A) 7LV A 401 (-3.6A)	0.38A	4ifgA-5tvtA: 24.4	4ifgA-5tvtA: 25.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ILE A 17 ALA A 38 LYS A 40 GLU A 57 TYR A 88 LEU A 139 ASP A 150	7LV A 401 (-4.3A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.74A	4qmnA-5tvtA: 28.3	4qmnA-5tvtA: 26.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMS_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 11	ILE A 17 ALA A 38 LYS A 40 GLU A 57 TYR A 88 LEU A 139 ASP A 150	7LV A 401 (-4.3A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.83A	4qmsA-5tvtA: 28.3	4qmsA-5tvtA: 26.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 12	ILE A 17 GLY A 18 VAL A 25 ALA A 38 TYR A 88 LEU A 139	7LV A 401 (-4.3A) 7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) 7LV A 401 (-4.9A)	0.39A	4qmzA-5tvtA: 28.4	4qmzA-5tvtA: 26.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 57 CYH A 89 LEU A 139 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.3A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.92A	4r7iA-5tvtA: 21.9	4r7iA-5tvtA: 26.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ALA A 38 LYS A 40 LEU A 61 CYH A 89 GLY A 92 HIS A 130 LEU A 139	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) None 7LV A 401 (-4.3A) None None 7LV A 401 (-4.9A)	0.74A	4u0iA-5tvtA: 22.2	4u0iA-5tvtA: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ALA A 38 LYS A 40 LEU A 61 CYH A 89 GLY A 92 LEU A 139 ASP A 150	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) None 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.86A	4u0iA-5tvtA: 22.2	4u0iA-5tvtA: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 11	GLY A 20 VAL A 25 ALA A 38 TYR A 88 GLY A 92 ASN A 137 LEU A 139 ASP A 150	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-4.6A) None None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.73A	4u5jA-5tvtA: 19.4	4u5jA-5tvtA: 26.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 12	VAL A 25 ALA A 38 LYS A 40 CYH A 89 ASP A 150 PHE A 151	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-4.3A) 7LV A 401 (-4.2A) None	0.91A	4xv2A-5tvtA: 23.0	4xv2A-5tvtA: 27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	ALA A 38 LYS A 40 CYH A 89 ASP A 150 PHE A 151	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-4.3A) 7LV A 401 (-4.2A) None	0.80A	4xv2B-5tvtA: 23.6	4xv2B-5tvtA: 27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	VAL A 25 ALA A 38 LYS A 40 CYH A 89 PHE A 151	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-4.3A) None	0.83A	5cswA-5tvtA: 23.1	5cswA-5tvtA: 27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	VAL A 25 ALA A 38 LYS A 40 CYH A 89 PHE A 151	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-4.3A) None	0.82A	5cswB-5tvtA: 22.9	5cswB-5tvtA: 27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	6 / 12	ALA A 38 LYS A 40 GLU A 57 LEU A 61 CYH A 89 HIS A 130	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) None 7LV A 401 (-4.3A) None	0.73A	5hi2A-5tvtA: 23.6	5hi2A-5tvtA: 27.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-D EPENDENT PROTEIN KINASE 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 11	GLY A 18 VAL A 25 ALA A 38 LEU A 86 TYR A 88 GLU A 93 LEU A 139	7LV A 401 ( 3.9A) 7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 ( 4.2A) 7LV A 401 (-4.6A) 7LV A 401 ( 4.7A) 7LV A 401 (-4.9A)	0.30A	5lvnA-5tvtA: 30.4	5lvnA-5tvtA: 28.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MAF_A_XINA403_2 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 5	LEU A 61 CYH A 70 CYH A 89 ASP A 150	None 7LV A 401 ( 3.7A) 7LV A 401 (-4.3A) 7LV A 401 (-4.2A)	0.72A	5mafA-5tvtA: 45.6	5mafA-5tvtA: 98.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MAF_A_XINA403_2 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 5	LEU A 61 CYH A 70 CYH A 89 LEU A 139	None 7LV A 401 ( 3.7A) 7LV A 401 (-4.3A) 7LV A 401 (-4.9A)	0.19A	5mafA-5tvtA: 45.6	5mafA-5tvtA: 98.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OWR_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 8	ALA A 38 GLU A 57 CYH A 89 LEU A 139 ASP A 150	7LV A 401 (-3.4A) 7LV A 401 (-3.5A) 7LV A 401 (-4.3A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.63A	5owrA-5tvtA: 22.3	5owrA-5tvtA: 28.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 12	GLU A 15 ILE A 17 GLY A 18 ALA A 38 GLU A 57 TYR A 88 CYH A 89 ASP A 150	None 7LV A 401 (-4.3A) 7LV A 401 ( 3.9A) 7LV A 401 (-3.4A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) 7LV A 401 (-4.3A) 7LV A 401 (-4.2A)	0.92A	5vc3A-5tvtA: 25.9	5vc3A-5tvtA: 24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ILE A 17 GLY A 18 GLU A 57 TYR A 88 CYH A 89 GLY A 92 ASP A 150	7LV A 401 (-4.3A) 7LV A 401 ( 3.9A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.2A)	0.88A	5vc3A-5tvtA: 25.9	5vc3A-5tvtA: 24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATED KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	7 / 12	ALA A 38 LYS A 40 GLU A 57 CYH A 89 GLY A 92 LEU A 139 ASP A 150	7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.85A	5y7zB-5tvtA: 25.4	5y7zB-5tvtA: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 57 CYH A 89 GLY A 92 LEU A 139 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.3A) None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.75A	5y80A-5tvtA: 25.0	5y80A-5tvtA: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 8	VAL A 25 LYS A 40 ILE A 149 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.0A) 7LV A 401 (-3.6A) 7LV A 401 (-4.2A)	0.59A	5y9mX-5tvtA: 22.8	5y9mX-5tvtA: 12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	4 / 7	VAL A 25 LYS A 40 ILE A 149 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.0A) 7LV A 401 (-3.6A) 7LV A 401 (-4.2A)	0.72A	5yf9B-5tvtA: 22.7	5yf9B-5tvtA: 12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	3 / 3	LYS A 40 LEU A 139 ASP A 150	7LV A 401 (-3.0A) 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	0.86A	5zv2A-5tvtA: 22.3	5zv2A-5tvtA: 14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	8 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 57 TYR A 88 GLY A 92 LEU A 139 ASP A 150	7LV A 401 ( 4.6A) 7LV A 401 (-3.4A) 7LV A 401 (-3.0A) 7LV A 401 (-3.5A) 7LV A 401 (-4.6A) None 7LV A 401 (-4.9A) 7LV A 401 (-4.2A)	1.39A	6bsdA-5tvtA: 21.9	6bsdA-5tvtA: 15.54

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MUO_A_ADNA1_1","AURORA-RELATED KINASE 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"GLY A  18;VAL A  25;ALA A  38;TYR A  88;LEU A 139","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.9A)","0.49A","1muoA-5tvtA:11.3",null],["1T46_A_STIA3_1","HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"VAL A  25;ALA A  38;LYS A  40;GLU A  57;LEU A  61;GLY A  92;LEU A 139;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);None;None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","1.01A","1t46A-5tvtA:22.2","1muoA-5tvtA:28.37"],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"ALA A  38;GLU A  57;LEU A  61;CYH A  89;HIS A 130","7LV A 401 (-3.4A);7LV A 401 (-3.5A);None;7LV A 401 (-4.3A);None","0.69A","1uwhA-5tvtA:23.7","1t46A-5tvtA:24.93"],["1UWH_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"ALA A  38;LYS A  40;GLU A  57;LEU A  61;CYH A  89;HIS A 130","7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);None;7LV A 401 (-4.3A);None","0.71A","1uwhB-5tvtA:23.6","1uwhA-5tvtA:26.38"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"ILE A  17;LEU A  61;ILE A  69;ASP A 150","7LV A 401 (-4.3A);None;None;7LV A 401 (-4.2A)","0.89A","1uwjA-5tvtA:7.3","1uwhB-5tvtA:26.38"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"ILE A  17;LYS A  40;LEU A  61;ILE A  69","7LV A 401 (-4.3A);7LV A 401 (-3.0A);None;None","0.75A","1uwjA-5tvtA:7.3","1uwjA-5tvtA:26.09"],["2EVA_A_ADNA498_1","TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"GLY A  18;GLY A  20;VAL A  25;ALA A  38;TYR A  88;LEU A 139","7LV A 401 ( 3.9A);7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.9A)","0.64A","2evaA-5tvtA:23.5","1uwjA-5tvtA:26.09"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"GLY A  18;VAL A  25;ALA A  38;LEU A  86;TYR A  88;ASP A 150","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 ( 4.2A);7LV A 401 (-4.6A);7LV A 401 (-4.2A)","0.52A","2wgjA-5tvtA:22.6","2evaA-5tvtA:28.86"],["2Y6O_A_1N1A1892_1","EPHRIN TYPE-A RECEPTOR 4","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ILE A  17;ALA A  38;LYS A  40;GLU A  57;TYR A  88;GLY A  92;LEU A 139","7LV A 401 (-4.3A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);None;7LV A 401 (-4.9A)","0.85A","2y6oA-5tvtA:23.1","2wgjA-5tvtA:23.71"],["3G0E_A_B49A9000_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"VAL A  25;ALA A  38;TYR A  88;CYH A  89;GLY A  92;LEU A 139","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.3A);None;7LV A 401 (-4.9A)","0.40A","3g0eA-5tvtA:21.4","2y6oA-5tvtA:26.21"],["3G0F_A_B49A9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"VAL A  25;ALA A  38;TYR A  88;CYH A  89;GLY A  92;LEU A 139","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.3A);None;7LV A 401 (-4.9A)","0.39A","3g0fA-5tvtA:22.4","3g0eA-5tvtA:23.50"],["3G0F_B_B49B9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"VAL A  25;ALA A  38;TYR A  88;CYH A  89;GLY A  92;LEU A 139","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.3A);None;7LV A 401 (-4.9A)","0.43A","3g0fB-5tvtA:22.4","3g0fA-5tvtA:23.50"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"VAL A  25;ALA A  38;LYS A  40;CYH A  89;PHE A 151","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-4.3A);None","0.79A","3og7A-5tvtA:23.3","3g0fB-5tvtA:23.50"],["3OHT_B_1N1B1000_1","P38A","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"GLY A  18;VAL A  25;ALA A  38;LYS A  40;LEU A  61","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);None","0.52A","3ohtB-5tvtA:6.4","3og7A-5tvtA:26.59"],["4BKJ_A_STIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"VAL A  25;ALA A  38;GLU A  57;MET A  84;TYR A  88;LEU A 139;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.5A);None;7LV A 401 (-4.6A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","1.22A","4bkjA-5tvtA:22.0","3ohtB-5tvtA:23.49"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",9,"VAL A  25;ALA A  38;ASP A  96;ASP A 132;LYS A 134;ASN A 137;LEU A 139;ILE A 149;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);None;None;None;None;7LV A 401 (-4.9A);7LV A 401 (-3.6A);7LV A 401 (-4.2A)","0.77A","4i41A-5tvtA:27.7","4bkjA-5tvtA:23.12"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"ALA A  38;LEU A  86;GLU A 136;LEU A 139;ILE A 149;ASP A 150","7LV A 401 (-3.4A);7LV A 401 ( 4.2A);None;7LV A 401 (-4.9A);7LV A 401 (-3.6A);7LV A 401 (-4.2A)","1.16A","4iaaA-5tvtA:27.7","4i41A-5tvtA:29.48"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"VAL A  25;ALA A  38;LYS A  40;LEU A  86;LEU A 139;ILE A 149;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 ( 4.2A);7LV A 401 (-4.9A);7LV A 401 (-3.6A);7LV A 401 (-4.2A)","0.64A","4iaaA-5tvtA:27.7","4iaaA-5tvtA:30.06"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"GLY A  18;VAL A  25;ALA A  38;LEU A  72;GLY A  92;GLU A  93;LEU A 139;ILE A 149","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);None;None;7LV A 401 ( 4.7A);7LV A 401 (-4.9A);7LV A 401 (-3.6A)","0.38A","4ifgA-5tvtA:24.4","4iaaA-5tvtA:30.06"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ILE A  17;ALA A  38;LYS A  40;GLU A  57;TYR A  88;LEU A 139;ASP A 150","7LV A 401 (-4.3A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.74A","4qmnA-5tvtA:28.3","4ifgA-5tvtA:25.73"],["4QMS_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ILE A  17;ALA A  38;LYS A  40;GLU A  57;TYR A  88;LEU A 139;ASP A 150","7LV A 401 (-4.3A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.83A","4qmsA-5tvtA:28.3","4qmnA-5tvtA:26.48"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"ILE A  17;GLY A  18;VAL A  25;ALA A  38;TYR A  88;LEU A 139","7LV A 401 (-4.3A);7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);7LV A 401 (-4.9A)","0.39A","4qmzA-5tvtA:28.4","4qmsA-5tvtA:26.48"],["4R7I_A_STIA1001_1","MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"VAL A  25;ALA A  38;LYS A  40;GLU A  57;CYH A  89;LEU A 139;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.3A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.92A","4r7iA-5tvtA:21.9","4qmzA-5tvtA:26.48"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ALA A  38;LYS A  40;LEU A  61;CYH A  89;GLY A  92;HIS A 130;LEU A 139","7LV A 401 (-3.4A);7LV A 401 (-3.0A);None;7LV A 401 (-4.3A);None;None;7LV A 401 (-4.9A)","0.74A","4u0iA-5tvtA:22.2","4r7iA-5tvtA:26.21"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ALA A  38;LYS A  40;LEU A  61;CYH A  89;GLY A  92;LEU A 139;ASP A 150","7LV A 401 (-3.4A);7LV A 401 (-3.0A);None;7LV A 401 (-4.3A);None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.86A","4u0iA-5tvtA:22.2","4u0iA-5tvtA:24.93"],["4U5J_A_RXTA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"GLY A  20;VAL A  25;ALA A  38;TYR A  88;GLY A  92;ASN A 137;LEU A 139;ASP A 150","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-4.6A);None;None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.73A","4u5jA-5tvtA:19.4","4u0iA-5tvtA:24.93"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"VAL A  25;ALA A  38;LYS A  40;CYH A  89;ASP A 150;PHE A 151","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-4.3A);7LV A 401 (-4.2A);None","0.91A","4xv2A-5tvtA:23.0","4u5jA-5tvtA:26.07"],["4XV2_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"ALA A  38;LYS A  40;CYH A  89;ASP A 150;PHE A 151","7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-4.3A);7LV A 401 (-4.2A);None","0.80A","4xv2B-5tvtA:23.6","4xv2A-5tvtA:27.46"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"VAL A  25;ALA A  38;LYS A  40;CYH A  89;PHE A 151","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-4.3A);None","0.83A","5cswA-5tvtA:23.1","4xv2B-5tvtA:27.46"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"VAL A  25;ALA A  38;LYS A  40;CYH A  89;PHE A 151","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-4.3A);None","0.82A","5cswB-5tvtA:22.9","5cswA-5tvtA:27.46"],["5HI2_A_BAXA801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",6,"ALA A  38;LYS A  40;GLU A  57;LEU A  61;CYH A  89;HIS A 130","7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);None;7LV A 401 (-4.3A);None","0.73A","5hi2A-5tvtA:23.6","5cswB-5tvtA:27.46"],["5LVN_A_ADNA402_1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"GLY A  18;VAL A  25;ALA A  38;LEU A  86;TYR A  88;GLU A  93;LEU A 139","7LV A 401 ( 3.9A);7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 ( 4.2A);7LV A 401 (-4.6A);7LV A 401 ( 4.7A);7LV A 401 (-4.9A)","0.30A","5lvnA-5tvtA:30.4","5hi2A-5tvtA:27.62"],["5MAF_A_XINA403_2","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"LEU A  61;CYH A  70;CYH A  89;ASP A 150","None;7LV A 401 ( 3.7A);7LV A 401 (-4.3A);7LV A 401 (-4.2A)","0.72A","5mafA-5tvtA:45.6","5lvnA-5tvtA:28.61"],["5MAF_A_XINA403_2","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"LEU A  61;CYH A  70;CYH A  89;LEU A 139","None;7LV A 401 ( 3.7A);7LV A 401 (-4.3A);7LV A 401 (-4.9A)","0.19A","5mafA-5tvtA:45.6","5mafA-5tvtA:98.75"],["5OWR_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 10","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",5,"ALA A  38;GLU A  57;CYH A  89;LEU A 139;ASP A 150","7LV A 401 (-3.4A);7LV A 401 (-3.5A);7LV A 401 (-4.3A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.63A","5owrA-5tvtA:22.3","5mafA-5tvtA:98.75"],["5VC3_A_DB8A601_1","WEE1-LIKE PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"GLU A  15;ILE A  17;GLY A  18;ALA A  38;GLU A  57;TYR A  88;CYH A  89;ASP A 150","None;7LV A 401 (-4.3A);7LV A 401 ( 3.9A);7LV A 401 (-3.4A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);7LV A 401 (-4.3A);7LV A 401 (-4.2A)","0.92A","5vc3A-5tvtA:25.9","5owrA-5tvtA:28.01"],["5VC3_A_DB8A601_1","WEE1-LIKE PROTEIN KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ILE A  17;GLY A  18;GLU A  57;TYR A  88;CYH A  89;GLY A  92;ASP A 150","7LV A 401 (-4.3A);7LV A 401 ( 3.9A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);7LV A 401 (-4.3A);None;7LV A 401 (-4.2A)","0.88A","5vc3A-5tvtA:25.9","5vc3A-5tvtA:24.23"],["5Y7Z_B_IREB401_0","CYCLIN-G-ASSOCIATED KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",7,"ALA A  38;LYS A  40;GLU A  57;CYH A  89;GLY A  92;LEU A 139;ASP A 150","7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.3A);None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.85A","5y7zB-5tvtA:25.4","5vc3A-5tvtA:24.23"],["5Y80_A_IREA401_0","CYCLIN-G-ASSOCIATED KINASE","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"VAL A  25;ALA A  38;LYS A  40;GLU A  57;CYH A  89;GLY A  92;LEU A 139;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.3A);None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.75A","5y80A-5tvtA:25.0","5y7zB-5tvtA:16.38"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"VAL A  25;LYS A  40;ILE A 149;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.0A);7LV A 401 (-3.6A);7LV A 401 (-4.2A)","0.59A","5y9mX-5tvtA:22.8","5y80A-5tvtA:16.38"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",4,"VAL A  25;LYS A  40;ILE A 149;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.0A);7LV A 401 (-3.6A);7LV A 401 (-4.2A)","0.72A","5yf9B-5tvtA:22.7","5y9mX-5tvtA:12.65"],["5ZV2_A_LEVA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",3,"LYS A  40;LEU A 139;ASP A 150","7LV A 401 (-3.0A);7LV A 401 (-4.9A);7LV A 401 (-4.2A)","0.86A","5zv2A-5tvtA:22.3","5yf9B-5tvtA:12.65"],["6BSD_A_1N1A901_0","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","5tvt","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","Homo sapiens",8,"VAL A  25;ALA A  38;LYS A  40;GLU A  57;TYR A  88;GLY A  92;LEU A 139;ASP A 150","7LV A 401 ( 4.6A);7LV A 401 (-3.4A);7LV A 401 (-3.0A);7LV A 401 (-3.5A);7LV A 401 (-4.6A);None;7LV A 401 (-4.9A);7LV A 401 (-4.2A)","1.39A","6bsdA-5tvtA:21.9","5zv2A-5tvtA:14.02"]]